+1,997.7%
SNDK vs THC
+105.9%
+1,891.7%
-67.7%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | THC | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.7% | -2.9% | +0.1% | -2.1% |
| 7D | -19.4% | -8.1% | -11.3% | -18.0% |
| 30D | -44.7% | -3.2% | -41.5% | -44.3% |
| 3M | -51.9% | -1.8% | -50.0% | -51.7% |
| 6M | -45.4% | +37.7% | -83.1% | -52.4% |
| YTD | +218.1% | +32.6% | +185.5% | +179.6% |
| 1Y | +207.0% | +35.7% | +171.3% | +167.6% |
| All | +1,997.7% | +105.9% | +1,891.7% | +1,354.3% |
Cumulative growth
Daily Returns
Daily percentage return beside THC.
Daily Out/Under-Performance
Portfolio return minus THC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × THC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded THC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling